Clinical Evaluation of the Use of Ginger Extract in the Management of Motion Sickness

• Status: Completed
• Trial end date: 2019-06-30
• Target enrollment: 0
• Participant gender: All

Summary

This is an open-label, case control study of 180 patients presenting motion sickness, who will perform a motion sickness assessment questionnaire before and after treatment with dry ginger (Z. officinale) extract.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Fundação Educacional Serra dos Órgãos
• Collaborator: Melora do Brasil Produtos Dermatológicos S/A

Criteria

Inclusion Criteria:

• Patients of both sexes between the ages of 18 and 65

• Clinical presentation of motion sickness

• Female participant of reproductive age agrees to use birth control during study period

• Patient has read, understood, signed and dated informed consent document

Exclusion Criteria:

• Hypersensitivity to any component of the study drug

• History of biliary calculus

• History of gastric irritation

• Hypertension > 145 / 100mmHg

• Concomitant use of other medicinal products for the treatment of motion sickness